These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 27575499)
1. Role of procalcitonin and c-reactive protein levels: a diagnostic tool in lower respiratory tract infections. Ben Amar J; Zaibi H; Bouzid K; Azzabi S; Bacca MA; Dahari B; Aouina H Tunis Med; 2016 Mar; 94(3):176-80. PubMed ID: 27575499 [TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of serum procalcitonin, IL-10 and C-reactive protein in community acquired pneumonia and tuberculosis. Niu WY; Wan YG; Li MY; Wu ZX; Zhang LG; Wang JX Eur Rev Med Pharmacol Sci; 2013 Dec; 17(24):3329-33. PubMed ID: 24379064 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan. Le Bel J; Hausfater P; Chenevier-Gobeaux C; Blanc FX; Benjoar M; Ficko C; Ray P; Choquet C; Duval X; Claessens YE; Crit Care; 2015 Oct; 19():366. PubMed ID: 26472401 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of serum procalcitonin in patients with community-acquired lobar pneumonia. Lee JY; Hwang SJ; Shim JW; Jung HL; Park MS; Woo HY; Shim JY Korean J Lab Med; 2010 Aug; 30(4):406-13. PubMed ID: 20805714 [TBL] [Abstract][Full Text] [Related]
5. Procalcitonin kinetics in Legionella pneumophila pneumonia. de Jager CP; de Wit NC; Weers-Pothoff G; van der Poll T; Wever PC Clin Microbiol Infect; 2009 Nov; 15(11):1020-5. PubMed ID: 19438643 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. Müller B; Harbarth S; Stolz D; Bingisser R; Mueller C; Leuppi J; Nusbaumer C; Tamm M; Christ-Crain M BMC Infect Dis; 2007 Mar; 7():10. PubMed ID: 17335562 [TBL] [Abstract][Full Text] [Related]
7. Serial procalcitonin levels for predicting prognosis in community-acquired pneumonia. Ito A; Ishida T; Tachibana H; Ito Y; Takaiwa T Respirology; 2016 Nov; 21(8):1459-1464. PubMed ID: 27398948 [TBL] [Abstract][Full Text] [Related]
8. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Schleicher GK; Herbert V; Brink A; Martin S; Maraj R; Galpin JS; Feldman C Eur Respir J; 2005 Apr; 25(4):688-92. PubMed ID: 15802344 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of diagnostic utility between procalcitonin and C-reactive protein for the patients with blood culture-positive sepsis]. Hur M; Moon HW; Yun YM; Kim KH; Kim HS; Lee KM Korean J Lab Med; 2009 Dec; 29(6):529-35. PubMed ID: 20046084 [TBL] [Abstract][Full Text] [Related]
10. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children. Agnello L; Bellia C; Di Gangi M; Lo Sasso B; Calvaruso L; Bivona G; Scazzone C; Dones P; Ciaccio M Clin Biochem; 2016 Jan; 49(1-2):47-50. PubMed ID: 26386341 [TBL] [Abstract][Full Text] [Related]
11. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia. Kang YA; Kwon SY; Yoon HI; Lee JH; Lee CT Korean J Intern Med; 2009 Dec; 24(4):337-42. PubMed ID: 19949732 [TBL] [Abstract][Full Text] [Related]
12. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia? Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331 [TBL] [Abstract][Full Text] [Related]
13. Procalcitonin and BISAP score versus C-reactive protein and APACHE II score in early assessment of severity and outcome of acute pancreatitis. Bezmarević M; Kostić Z; Jovanović M; Micković S; Mirković D; Soldatović I; Trifunović B; Pejović J; Vujanić S Vojnosanit Pregl; 2012 May; 69(5):425-31. PubMed ID: 22764546 [TBL] [Abstract][Full Text] [Related]
16. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Prat C; Domínguez J; Rodrigo C; Giménez M; Azuara M; Jiménez O; Galí N; Ausina V Pediatr Infect Dis J; 2003 Nov; 22(11):963-8. PubMed ID: 14614368 [TBL] [Abstract][Full Text] [Related]
17. [Usefulness of serum procalcitonin measurement in the diagnosis of respiratory infectious diseases]. Kurata K; Kazuyori T; Shimizu K; Kubota M; Hamaguchi R; Wakaki M; Goto T; Onaka A; Kato R; Oyamada Y Nihon Kokyuki Gakkai Zasshi; 2010 Sep; 48(9):654-60. PubMed ID: 20954366 [TBL] [Abstract][Full Text] [Related]
18. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis. Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057 [TBL] [Abstract][Full Text] [Related]
19. Assessment of inflammatory markers in patients with community-acquired pneumonia--influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ. Krüger S; Ewig S; Kunde J; Hartmann O; Marre R; Suttorp N; Welte T; Clin Chim Acta; 2010 Dec; 411(23-24):1929-34. PubMed ID: 20699094 [TBL] [Abstract][Full Text] [Related]
20. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Fernández Lopez A; Luaces Cubells C; García García JJ; Fernández Pou J; Pediatr Infect Dis J; 2003 Oct; 22(10):895-903. PubMed ID: 14551491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]